Key facts
- Lenoss Medical’s last known valuation is $25.0M (Mar 2026).
- It has raised $11.3M across 1 recorded rounds; the latest was Seed Round ($1.3M) in Feb 2021.
- Notable investors include AZ Venture Capital, Beacon Angels, Highpoint Ventures, Angel Capital Association, Cherrystone Angel Group — 14 tracked in total.
- Lenoss Medical has filed 1 Form D with the SEC, most recently Mar 2021 ($1.3M sold to 32 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Lenoss Medical
Funding rounds
1 roundsAbout Lenoss Medical
Developer of surgical and medical instruments designed to treat spinal fractures. The company's cement-free technology utilizes the natural healing properties of healthy bone, enabling osteoporotic patients to heal without causing additional problems.
- Sector
- Healthcare
- HQ
- Providence, RI, United States
- Founded
- 2017
- Employees
- 9
- Website
- lenoss.com/
- Ownership
- Privately Held (backing)
Lenoss Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lenoss Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lenoss Medical in its N-PORT filings yet. We sweep new filings monthly.